Chemoinformaics analysis of 1-Acetyl-Beta-Carboline
| Molecular Weight | 210.236 | nRot | 1 |
| Heavy Atom Molecular Weight | 200.156 | nRig | 16 |
| Exact Molecular Weight | 210.079 | nRing | 3 |
| Solubility: LogS | -3.2 | nHRing | 2 |
| Solubility: LogP | 2.297 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 15 |
| nHA | 2 | APOL | 31.3799 |
| nHD | 1 | BPOL | 12.6101 |
| QED | 0.627 |
| Synth | 2.155 |
| Natural Product Likeliness | 0.233 |
| NR-PPAR-gamma | 0.349 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.013 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.88 |
| MDCK | 0.0000181 |
| BBB | 0.896 |
| PPB | 0.835005 |
| VDSS | 1.183 |
| FU | 0.119242 |
| CYP1A2-inh | 0.992 |
| CYP1A2-sub | 0.856 |
| CYP2c19-inh | 0.712 |
| CYP2c19-sub | 0.271 |
| CYP2c9-inh | 0.33 |
| CYP2c9-sub | 0.87 |
| CYP2d6-inh | 0.699 |
| CYP2d6-sub | 0.729 |
| CYP3a4-inh | 0.574 |
| CYP3a4-sub | 0.235 |
| CL | 3.323 |
| T12 | 0.403 |
| hERG | 0.024 |
| Ames | 0.474 |
| ROA | 0.974 |
| SkinSen | 0.78 |
| Carcinogencity | 0.395 |
| EI | 0.982 |
| Respiratory | 0.987 |
| NR-Aromatase | 0.53 |
| Antiviral | Yes |
| Prediction | 0.700594 |